CARDIAC EFFECTS GLUCAGON‐LIKE PEPTIDE 1 WITH CHITOSAN‐BASED SCAFFOLD AFTER INDUCING MYOCARDIAL INFARCTION IN CANINES

Publisher： John Wiley & Sons Inc

E-ISSN： 1445-5994|45|S3|22-22

ISSN： 1444-0903

Source： INTERNAL MEDICINE JOURNAL, Vol.45, Iss.S3, 2015-05, pp. : 22-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of gastric inhibitory polypeptide, glucagon‐like peptide‐1 and glucagon‐like peptide‐1 receptor agonists on Bone Cell Metabolism

By  

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 122, Iss. 1, 2018-01 ,pp. : 25-37

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of glucagon‐like peptide‐1 receptor agonists on cardiovascular risk factors: A narrative review of head‐to‐head comparisons

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 3, 2018-03 ,pp. : 508-519

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cell-based delivery of glucagon-like peptide-1 using encapsulated mesenchymal stem cells

By Wallrapp Christine  

Journal of Microencapsulation, Vol. 30, Iss. 4, 2013-06 ,pp. : 315-324

Informa Healthcare

Access to resources Recommend Favorite

Overnight hypoxic exposure and glucagon-like peptide-1 and leptin levels in humans

By Snyder Eric M.   Carr Richard D.   Deacon Carolyn F.   Johnson Bruce D.  

Applied Physiology, Nutrition, and Metabolism, Vol. 33, Iss. 5, 2008-10 ,pp. : 929-935

NRC Research Press

Access to resources Recommend Favorite

Xenopus‐derived glucagon‐like peptide‐1 and polyethylene‐glycosylated glucagon‐like peptide‐1 receptor agonists: long‐acting hypoglycaemic and insulinotropic activities with potential therapeutic utilities

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 175, Iss. 3, 2018-02 ,pp. : 544-557

John Wiley & Sons Inc

Access to resources Recommend Favorite